Search PubMed⌕ Search

Biomedical subjects

C H Collins

Publications and source records attributed to C H Collins.

At least 19 recordsLinked to original sources
PubMed1992

Safe biotechnology (4). Recommendations for safety levels for biotechnological operations with microorganisms that cause diseases in plants.

The Working Party on Safety in Biotechnology of the European Federation of Biotechnology has proposed a classification of microorganisms that cause diseases in plants. In this paper appropriate safety levels are proposed for these classes of microorganisms in order to ensure that research, development and industrial fermentation work with plant pathogens will limit the risk of outbreaks of diseases in crops that could result from work with such microorganisms when they are cultivated in laboratories, glasshouses and biotechnology installations.

Containment of Biohazards↗
PubMed1991

A comparison of APACHE II and a clinical sickness score. A study of 97 consecutive admissions to a district general hospital intensive care unit.

The aim of this study was to compare the predictive power of a simple illness severity score (Clinical Sickness Score) to that of APACHE II in a District General Hospital intensive therapy unit. A prospective comparison was carried out on 97 consecutive adult patients whose severity of illness was scored one hour after admission using both the Clinical Sickness Score and APACHE II. Intensive Therapy Unit and hospital outcomes were recorded for each patient. The Clinical Sickness Score and APACHE II identified survivors and nonsurvivors with similar power (p less than 0.001). There was a highly significant correlation between the two scoring systems for hospital survivors and nonsurvivors together (r = 0.5418, r2 = 0.28, p = less than 0.0001) and for hospital survivors alone (r = 0.6102, r2 = 0.37, p = 0.0001). Correlation for hospital nonsurvivors was not significant (r = 0.1629, r2 = 0.027, p = 0.3134). The positive predictive values of APACHE II were between 5% and 10% more sensitive than the Clinical Sickness Score for hospital outcome. Admission Clinical Sickness Score and APACHE II scores had similar predictive power in this study.

Adult↗
PubMed1991

Treatment and disposal of clinical and laboratory waste.

There are no entirely satisfactory definitions of clinical waste; nor are there methods in general use that are safe and environmentally acceptable for the storage, transport and final disposal of the ever-increasing volume of such waste that is generated by the health services. Hazardous, potentially infectious and aesthetically objectionable waste has been found on beaches and exposed on domestic refuse landfill sites, causing public disquiet about health hazards and environmental pollution. Landfill is officially discouraged, where not illegal, and many older-type incinerators can not now be used because their effluent pollutes the atmosphere. Modern and efficient incinerators are expensive and the parochial nature of health service management and accounting mitigates against their installation and use. Laboratory waste, however, can be rendered safe and unobjectionable, aesthetically and environmentally, if the requirements and recommendations of the several Codes of Practice and technical advice, which are simple and inexpensive, are implemented by laboratory and hospital managers.

Hazardous Waste↗
PubMed1990

Protocol for increasing organ donation after cerebrovascular deaths in a district general hospital.

In a district general hospital serving 303,000 people, deaths from cerebrovascular incidents over 12 months were analysed retrospectively. 8 patients who died in general wards were identified as potential organ donors. A working party then devised a protocol for managing such donors by transfer to the intensive care unit for support until organ retrieval could be arranged. In the first 19 months with the protocol, organs (1 heart, 2 sets of heart valves, 2 livers, and 16 kidneys) were retrieved from 8 patients who would not otherwise have become donors. If these results were replicated nationally a further 16.7 donors per million per year would be added to the current annual UK rate of 14.6 donors per million.

Adult↗
PubMed1989

Comparison of propofol and midazolam for sedation in critically ill patients.

101 critically ill patients admitted to five intensive-care units were allocated randomly to receive a continuous intravenous infusion of either propofol or midazolam for sedation for up to 24 h. In addition, morphine was given to provide analgesia. The mean duration of infusion was 20.2 h (range 3.0-24.5) in the propofol group and 21.3 h (4.0-47.0) in the midazolam group and infusion rates were 1.77 mg/kg/h (range 0.40-5.00) and 0.10 mg/kg/h (0.01-0.26), respectively. The infusion rates were adjusted as necessary, and the desired level of sedation was achieved easily in most patients in both groups. There were slight falls in arterial pressure, but there were no significant differences between the groups. Heart rate was lower in patients who received propofol. Some small changes occurred in biochemical and haematological variables in both groups, but they were not clinically significant. There was no indication that either drug substantially impaired adrenal steroidogenesis. When the infusion was discontinued, there was less variability in recovery of consciousness in patients who had received propofol. In a subgroup of patients, weaning from mechanical ventilation was achieved significantly faster after discontinuation of propofol than of midazolam. Propofol proved to be a satisfactory agent for sedation of these critically ill patients and compared favourably with midazolam.

Adolescent↗
PubMed1989

High-level vancomycin-resistant enterococci causing hospital infections.

Nosocomial infection or colonization due to enterococci with high-level resistance to vancomycin (minimal inhibitory concentrations [MICs] between 64 and greater than 2000 mg/L) has occurred in 41 patients with renal disease. These vancomycin-resistant enterococci were cultured from many sources including blood. All but one strain contained one or more plasmids ranging in molecular weight from 1.0 to 40 Megadaltons (MDa). Vancomycin resistance was transferable by conjugation to a susceptible recipient strain of Enterococcus faecalis but this was not always associated with plasmid DNA. The emergence of transferable high-level vancomycin resistance in enterococci causing significant clinical infections is of particular importance since vancomycin is widely regarded as a reserve drug for the management of infections with multi-resistant Gram-positive organisms.

Acute Kidney Injury↗
PubMed1988

In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.

Within attainable serum concentrations, quinolones, especially ciprofloxacin, inhibited strains of Mycobacterium tuberculosis, M. xenopi, M. kansasii, M. fortuitum and M. marinum; vancomycin inhibited M. tuberculosis, the M. avium-intracellulare-scrofulaceum complex. M. kansasii, M. xenopi and M. chelonei; erythromycin was active against M. kansasii, M. xenopi and M. fortuitum, minocycline against M. kansasii and M. marinum and netilmicin and cefuroxime against M. xenopi. Aztreonam showed some activity against M. tuberculosis but little or no effect was shown by five cephalosporins or imipenem.

Anti-Bacterial Agents↗
PubMed1988

Presumptive identification of nocardias in a clinical laboratory.

One hundred and thirty-six cultures of aerobic streptomycetes were examined by simple cultural and microscopical methods. Nocardia spp. were recognized by their resistance to lysozyme and identified to the three important species by casein, xanthine and tyrosine hydrolysis tests.

Actinomycetales↗